• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

OIKE Naoki  大池 直樹

ORCIDConnect your ORCID iD *help
… Alternative Names

OIKE NAOKI  大池 直樹

Less
Researcher Number 20961676
Other IDs
Affiliation (Current) 2026: 新潟大学, 医歯学総合病院, 助教
Affiliation (based on the past Project Information) *help 2022 – 2024: 新潟大学, 医歯学総合病院, 助教
Review Section/Research Field
Principal Investigator
Basic Section 56020:Orthopedics-related / 0901:Oncology and related fields
Except Principal Investigator
Basic Section 56020:Orthopedics-related
Keywords
Principal Investigator
滑膜肉腫 / 軟部肉腫 / NK細胞 / 免疫療法 / 免疫 / Ewing様肉腫 / キメラ受容体T細胞 / CAR-T / 脂肪肉腫 / HLA classI … More
Except Principal Investigator
… More 筋委縮 / がん骨転移 / 乳がん / サルコペニア / 骨粗鬆症 / スクレロスチン Less
  • Research Projects

    (3 results)
  • Research Products

    (11 results)
  • Co-Researchers

    (2 People)
  •  がん骨転移と筋委縮に対する抗スクレロスチン抗体療法

    • Principal Investigator
      川島 寛之
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56020:Orthopedics-related
    • Research Institution
      Niigata University
  •  Novel immunotherapy for Ewing like sarcomaPrincipal Investigator

    • Principal Investigator
      大池 直樹
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 56020:Orthopedics-related
    • Research Institution
      Niigata University
  •  Development of novel NK cell therapy for soft tissue sarcomaPrincipal Investigator

    • Principal Investigator
      OIKE NAOKI
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Niigata University

All 2024 2023 2022

All Presentation

  • [Presentation] Adoptive natural killer therapy is effective for synovial sarcoma cell lines2024

    • Author(s)
      Naoki Oike, Tomohiro Miyazaki, Takashi Ariizumi,Akira Ogose, Minori Baba, Hiroyuki Kawashima, Chihaya Imai
    • Organizer
      AACR annual meeting 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] Adoptive natural killer therapy is effective for syovial sarcoma cell lines2024

    • Author(s)
      Naoki, Oike, Tomohiro Miyazaki, Yudai Murayama, Takashi Ariizumi, Akira Ogose, Minori Baba, Hiroyuki Kawashima, Chihaya Imai
    • Organizer
      AACR 2024 annual meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K20787
  • [Presentation] Effectiveness of natural killer therapy against synovial sarcoma cell line2024

    • Author(s)
      Naoki Oike, Tomohiro Miyazaki, Yudai Murayama, Akira Ogose, Takashi Ariizumi, Minori Baba, Yuko Suzuki, Hiroyuki Kawashima, Chihaya Imai
    • Organizer
      22nd International society of limb salvage General meeting 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] CAR-T cell therapies are effective for synovial sarcoma cell lines; HER2-targeted CAR-T and NKG2D-based CAR-T2024

    • Author(s)
      Naoki Oike, Tomohiro Miyazaki, Yudai Murayama, Minori Baba, Yuko Suzuki, Yasushi Kasahara, Nobuhiro Kubo, Akira Ogose, Hiroyuki Kawashima, Chihaya Imai
    • Organizer
      22nd International society of limb salvage General meeting 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] 滑膜肉腫に対するCAR-T細胞療法2024

    • Author(s)
      宮崎友宏、川島寛之、村山雄大、大池直樹、有泉高志、生越章、今井千速
    • Organizer
      第57回日本整形外科学会骨・軟部腫瘍学術集会
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] 滑膜肉腫に対するNK 細胞活性化受容体リガンド(NKG2D ligands)を標的とした第2/3 世代CAR-T 細胞療法2024

    • Author(s)
      宮崎友宏, 今井千速, 村山雄大, 大池直樹, 有泉高志, 生越章, 笠原靖史, 久保暢大, 馬場みのり, 川島寛之
    • Organizer
      第39回日本整形外科学会基礎学会
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] Effectiveness and comparsion of CAR-T cell therapies for synovial sarcoma; HER-2 targeted CAR-T and NK2GD based CAR-T cell2024

    • Author(s)
      Tomohiro Miyazaki, , Chihaya Imai, Naoki Oike,Yudai Murayama, Takashi Ariizumi, Minori Baba, Yasushi Kasahara, Hiroyuki Kawashima
    • Organizer
      AACR annual meeting 2024
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] 滑膜肉腫に対する免疫細胞療法の試み2024

    • Author(s)
      大池直樹,宮崎友宏, 村山雄大, 有泉高志, 生越章, 川島寛之,今井千速
    • Organizer
      第39回日本整形外科学会基礎学会
    • Data Source
      KAKENHI-PROJECT-24K19610
  • [Presentation] 滑膜肉腫に対するNK細胞活性化受容体を利用したCAR-T細胞の検討2023

    • Author(s)
      宮崎友宏, 今井千速, 大池直樹, 村山雄大, 有泉高志, 生越章, 笠原靖史, 久保暢大, 馬場みのり, 川島寛之
    • Organizer
      第38回日本整形外科基礎学術集かあい
    • Data Source
      KAKENHI-PROJECT-22K20787
  • [Presentation] HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA2022

    • Author(s)
      Naoki Oike, Ryota Shirai, Taylor Gillis, Deandra Walker, Avery Bodlak, Timothy Porfilio, Michael Verneris, Masanori Hayashi
    • Organizer
      2022 CTOS annual meeting
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K20787
  • [Presentation] Glycogen synthase kinase 3阻害薬はEwing肉腫においてNK細胞の抗腫瘍効果を増強する2022

    • Author(s)
      大池 直樹, 白井 了太, 生越 章, 有泉 高志, 村山 雄大, Bodlak Avery, 川島 寛之, Verneris Michael, 林 正憲
    • Organizer
      第37回日本整形外科学会基礎学術集会
    • Data Source
      KAKENHI-PROJECT-22K20787
  • 1.  川島 寛之 (30361900)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  湊 圭太郎 (90970608)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi